| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of Revenue | $1.0B | $0.8B | $0.6B | $0.2B | $0.1B |
| Gross Profit | $3.0B | $2.3B | $1.6B | $0.6B | $0.3B |
| R&D Expense | $1.1B | $0.8B | $0.6B | $0.2B | $0.1B |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $-0.1B | $-0.0B | $-0.2B | $-0.1B | $-0.1B |
| Net Income | $-0.0B | $0.1B | $-0.2B | $-0.1B | $-0.1B |
| EPS (Basic) | $-0.08 | $0.37 | $-0.79 | — | — |
| EPS (Diluted) | $-0.08 | $0.37 | $-0.79 | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Total Assets | $8.7B | $6.6B | $5.0B | $2.7B | $1.4B |
| Current Assets | $6.1B | $4.8B | $3.6B | $2.3B | $1.2B |
| Cash & Equivalents | $4.3B | $3.4B | $2.5B | — | — |
| Total Liabilities | $5.4B | $4.3B | $3.5B | $1.9B | $0.7B |
| Current Liabilities | $3.5B | $2.7B | $2.1B | $0.9B | $0.5B |
| Stockholders' Equity | $3.3B | $2.3B | $1.5B | $0.9B | $0.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.2B | $0.9B | $0.4B | $0.1B |
| Investing Cash Flow | $-0.5B | $-0.3B | $-0.6B | $0.5B | $-0.6B |
| Capital Expenditures | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B |
| Financing Cash Flow | $0.1B | $0.1B | $0.1B | $0.8B | $0.7B |